Insight journal - Company

Stada: Partnering activity 2005-2013

Posted on 16 January 2014

Tags: , ,

Stada, an international generic pharmaceutical company, focuses on products with off-patent active pharmaceutical ingredients. The company’s business model relies on organic growth supported by acquisitions with a focus on high growth emerging markets with high branded product segment.

The following figure shows the level of partnering by Stada in the last few years. Being the only independent generics producer in Germany and having a strong presence in Europe, Stada partners to market branded products.

Figure 1: Stada partnering deals 2005-2013

Figure 1: Stada partnering deals 2005-2013

Source: Current Agreements, 2013

Further analysis of the partnering deals shows a strong emphasis on partnerships in areas of CNS, cardiovascular, gastrointestinal, genitourinary and hemtaology.

The following table provides an overview of the partnering deals announced by Stada based on therapy area disclosed. Our report provides more detailed insight into the precise therapeutic target of each deal. See: Partnering Agreements with Stada 2005-2013

Figure 2: Stada partnering deals by therapy area 2005-2013

 

Figure 2: Stada partnering deals by therapy area 2005-2013

 

Source: Current Agreements, 2013

The following table provides an overview of the partnering deals announced by Stada based on deal type disclosed. Most of the partnerships entered by Stada are licensing, asset purchase and distribution agreements for generic and branded products in the international markets.

Figure 3: Stada partnering deals by deal type 2005-2013

Figure 3: Stada partnering deals by deal type 2005-2013

 

Source: Current Agreements, 2013

Further analysis of these deals shows that Stada has a preference for marketed and formulation deals. Stada focuses on development and marketing of active ingredients that are free of IP rights.

The following table provides an overview of the partnering deals announced by Stada based on stage of development at signature

Figure 4: Stada partnering by stage of development 2005-2013

Figure 4: Stada partnering by stage of development 2005-2013

 

Source: Current Agreements, 2013

The following provides two of the top deals by headline value signed by Stada

Figure 5: Top Stada partnering deals by headline value 2005-2013

Figure 5: Top Stada partnering deals by headline value 2005-2013

 

Source: Current Agreements, 2013

Our report provides more detailed insight into the details of each deal. See: Partnering Agreements with Stada 2005-2013

Stada partnering at Current Agreements

View all partnering deals for Stada: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Partnering Agreements with Stada 2005-2013

More

Summary profile data for STADA

Partnering interests for STADA

M&A activity for STADA

 

Available reports from Current Partnering

Report: Partnering Agreements with Stada 2005-2013 

Report: Partnering Deals and Alliances with Big Pharma

 

Available resources for deal coverage for Stada

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Stada company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

 

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

 

Print Friendly, PDF & Email

Leave a Reply

 

cabannerad300x150new4gif
rauconbadgejpg
e80banner300x150animgif
cabannerad300x150new4gif
e80banner300x150animgif
a1banner300x150animgif